Traitement médicamenteux < Traitement médicamenteux () < Traitement médicamenteux (économie)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f

List of bibliographic references indexed by Traitement médicamenteux ()

Number of relevant bibliographic references: 13.

Ident.	Authors (with country if any)	Title
000493 (2017)	Chet Raj Ojha [États-Unis] ; Basant Joshi [Népal] ; Khagendra Prakash Kc [Népal] ; Shyam Prakash Dumre [Japon] ; Keshav Kumar Yogi [Népal] ; Bandana Bhatta [Népal] ; Tulasi Adhikari [Népal] ; Kathryn Crowley [États-Unis] ; Babu Ram Marasini [Népal]	Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
002845 (2014)	Anil Kumar ; Pawan Sachan	Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA).
002A00 (2014)	A N Shriram [Inde] ; K. Krishnamoorthy [Inde] ; Arun Sivan [Inde] ; B P Saha [Inde] ; V. Kumaraswami [Inde] ; P. Vijayachari [Inde]	Impact of MDA and the prospects of elimination of the lone focus of diurnally sub periodic lymphatic filariasis in Nicobar Islands, India.
003393 (2013)	Wilma A. Stolk [Pays-Bas] ; Quirine A. Ten Bosch [Pays-Bas] ; Sake J. De Vlas [Pays-Bas] ; Peter U. Fischer [États-Unis] ; Gary J. Weil [États-Unis] ; Ann S. Goldman [États-Unis]	Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
003570 (2013)	Joseph B. Koroma [Sierra Leone, Burkina Faso, Royaume-Uni] ; Santigie Sesay [Sierra Leone] ; Mustapha Sonnie [Sierra Leone] ; Mary H. Hodges [Sierra Leone] ; Foday Sahr [Sierra Leone] ; Yaobi Zhang [Sénégal] ; Moses J. Bockarie [Royaume-Uni]	Impact of Three Rounds of Mass Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone
003956 (2013)	Alison Krentel [États-Unis, Royaume-Uni] ; Peter U. Fischer [États-Unis] ; Gary J. Weil [États-Unis]	A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
004333 (2012)	Subramanian Swaminathan ; Vanamail Perumal ; Srividya Adinarayanan ; Krishnamoorthy Kaliannagounder ; Ravi Rengachari ; Jambulingam Purushothaman	Epidemiological Assessment of Eight Rounds of Mass Drug Administration for Lymphatic Filariasis in India: Implications for Monitoring and Evaluation
004361 (2012)	R. Noordin [Malaisie] ; J. Muhi ; Z. Md Idris ; N. Arifin ; A. Kiyu	Duration of detection of anti-BmR1 IgG4 antibodies after mass-drug administration (MDA) in Sarawak, Malaysia.
004D64 (2011)	Louise A. Kelly-Hope [Royaume-Uni] ; Brent C. Thomas [Royaume-Uni] ; Moses J. Bockarie [Royaume-Uni] ; David H. Molyneux [Royaume-Uni]	Lymphatic filariasis in the Democratic Republic of Congo; micro-stratification overlap mapping (MOM) as a prerequisite for control and surveillance
004F73 (2011)	Ann S. Goldman ; Molly A. Brady ; Abdel Direny ; Luccene Desir ; Roland Oscard ; Jean-Francois Vely ; Mary Linehan ; Margaret Baker	Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti
005790 (2010)	A K Mukhopadhyay [Inde]	Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme.
005965 (2010)	B G Ranganath [Inde]	Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
007182 (2007)	Ann S. Goldman [États-Unis] ; Victoria H. Guisinger [États-Unis] ; Moses Aikins [Ghana] ; Maria Lourdes E. Amarillo ; Vicente Y. Belizario ; Bertha Garshong [Ghana] ; John Gyapong [Ghana] ; Conrad Kabali [Tanzanie] ; Hussein A. Kamal [Égypte] ; Sanjat Kanjilal [États-Unis] ; Dominique Kyelem [Burkina Faso] ; Jefrey Lizardo [République dominicaine] ; Mwele Malecela [Tanzanie] ; Godfrey Mubyazi [Tanzanie] ; P. Abdoulaye Nitièma [Burkina Faso] ; Reda M. R. Ramzy [Égypte] ; Thomas G. Streit [États-Unis] ; Aaron Wallace [États-Unis] ; Molly A. Brady [États-Unis] ; Richard Rheingans [États-Unis] ; Eric A. Ottesen [États-Unis] ; Anne C. Haddix [États-Unis]	National Mass Drug Administration Costs for Lymphatic Filariasis Elimination

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Traitement médicamenteux ()" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Traitement médicamenteux ()" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Traitement médicamenteux ()
}}

---

This area was generated with Dilib version V0.6.31. Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024